Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 trial comparing concurrent versus sequential sipuleucel-T and abiraterone in metastatic castration-resistant prostate cancer has com…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer [Phase 4]
Phase 4 study evaluating enzalutamide after abiraterone treatment in metastatic castration-resistant prostate cancer has completed and poste…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 1]
A Phase 1 trial assessing imaging-based response to Radium-223 dichloride in metastatic, hormone-resistant prostate cancer; the study has be…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase II study evaluating DCVAC/PCa added to standard chemotherapy for metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer [Phase 3]
Phase 3 trial evaluating orteronel plus prednisone in chemotherapy-naive metastatic castration-resistant prostate cancer has completed and p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer
A clinical trial update examining expression of molecular markers in circulating tumor cells from patients with metastatic castration-resist…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial update evaluating whether dietary fat levels affect uptake of abiraterone acetate in metastatic hormone-resistant pro…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: BKM120 in Metastatic Castration-resistant Prostate Cancer [Phase 2]
A Phase 2 trial of buparlisib (BKM120) for metastatic castration-resistant prostate cancer was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer [Phase 2]
A Phase 2 trial evaluating navitoclax with abiraterone acetate, with or without hydroxychloroquine, in progressive metastatic castration-res…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update showing safety and pharmacokinetics data for ODM-201 (darolutamide) in castration-resistant prostate cancer;…
-
CLINICAL_TRIALS research · 2017-03-21Clinical Trial Update: Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC [Phase 1, Phase 2]
ClinicalTrials.gov update describes a Phase 1/2 study evaluating autologous immune cell therapy in combination with a luteinizing hormone-re…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Metformin in Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial of metformin in castration-resistant prostate cancer was terminated, with results posted in 2017 by Massachusetts General Hosp…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) [Phase 2]
Phase 2 trial of a PSMA-targeted antibody-drug conjugate in metastatic castration-resistant prostate cancer has completed enrollment and pos…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: An Open-label Extension Study of PSMA ADC 2301 in mCRPC [Phase 2]
An open-label extension study of PSMA ADC 2301 in metastatic castration-resistant prostate cancer (Phase 2) has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer [Phase 1, Phase 2]
Clinical trial update indicates termination of a Phase 1/2 study evaluating an RNActive-derived vaccine for metastatic castration-resistant …
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
This clinical trial update provides expanded access to MDV3100 (enzalutamide) for patients with progressive castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone [Phase 2]
Phase 2 SWITCH study evaluated switching from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients treate…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001 [Phase 2]
Phase 2 extension study report on ODM-201 (darolutamide) in castration-resistant prostate cancer, focusing on safety and tolerability.
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) [Phase 2]
Phase 2 trial evaluating mitoxantrone with or without cetuximab as second-line therapy for castration-resistant prostate cancer; the study c…
-
CLINICAL_TRIALS withdrawal · 2016-11-22Clinical Trial Update: A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer [Phase 2]
A Phase 2 study evaluating JNJ-64041809 in combination with apalutamide versus apalutamide for metastatic castration-resistant prostate canc…
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Phase 1/2 study assessing Alpharadin in combination with Docetaxel in patients with bone metastases from castration-resistant prostate cance…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Second-line Chemotherapy in Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 trial testing second-line chemotherapy for metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2016-10-12Clinical Trial Update: A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) [Phase 3]
A Phase 3 trial evaluating custirsen added to docetaxel retreatment or cabazitaxel as second-line therapy for metastatic castration-resistan…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 3]
A Phase 3 trial compares cabazitaxel at 20 mg/m² vs 25 mg/m² with prednisone in metastatic castration-resistant prostate cancer; results hav…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
This completed Phase 1 trial evaluated the safety and pharmacokinetics of escalating doses of DSTP3086S in patients with metastatic castrati…